Skip to main content
TipRanks
Go Ultimate75% OFF

Altamira Therapeutics (CYTOF) Income Statement

600 Followers

Altamira Therapeutics Income Statement

Last quarter (Q2 2023), Altamira Therapeutics's total revenue was CHF52.73K, a decrease of 63.73% from the same quarter last year. In Q2, Altamira Therapeutics's net income was CHF-2.71M. See Altamira Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 23Dec 22Dec 21Dec 20Dec 19
CHF 0.00CHF 305.62KCHF 63.88KCHF 174.47KCHF -56.00K
CHF 0.00CHF -1.14MCHF -2.18MCHF 174.47KCHF -56.00K
CHF 6.54MCHF 24.99MCHF 14.92MCHF 5.46MCHF 7.26M
Depreciation and AmortizationCHF 5.92MCHF 118.89KCHF 76.36KCHF 20.04KCHF 30.82K
CHF -1.35MCHF -17.64MCHF -6.72MCHF -5.26MCHF -7.24M
CHF -5.92MCHF -26.13MCHF -17.10MCHF -5.28MCHF -7.26M
CHF -1.35MCHF -645.64KCHF -1.46MCHF -2.94MCHF 433.41K
CHF -7.27MCHF -26.54MCHF -17.37MCHF -8.22MCHF -6.83M
CHF -7.27MCHF -26.53MCHF -17.39MCHF -8.20MCHF -6.63M
Per Share Metrics
Basic EPSCHF -14.81CHF -582.58CHF -525.13CHF -545.41CHF -455.96
Diluted EPSCHF -14.80CHF -582.58CHF -525.13CHF -545.41CHF -455.96
Weighted Average Shares Outstanding491.00K45.54K33.12K15.04K14.54K
Weighted Average Shares Outstanding (Diluted)491.26K45.54K33.12K15.04K14.54K

Currency in CHF

Altamira Therapeutics Earnings and Revenue History

-30M-15M015M-30000 %-15000 %0 %15000 %EarningsProfit Margin201820192020202120222023RevenueEarningsProfit Margin